GeneralConnection.com ➔ Dictionary
Dictionary Search

haemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
Get easily bruised? It may be due to haemophilia B - Healthshots
Gene Therapy For Hemophilia: What Hematologists Need To Tell Patients - BW Healthcare World
NMPA approves BBM and Takeda China’s haemophilia B therapy - Pharmaceutical Technology
Belief, Takeda’s home-grown haemophilia B gene therapy gains nod in China - FirstWord Pharma
After 4 years, hemophilia B bleeding rates remain low with Hemgenix - Hemophilia News Today
Hemophilia B Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | UniQure Biopharma B.V., CSL Behring, Pfizer/Spark Therapeutics, Genzyme Sanofi - Barchart.com
Universal hope for hemophilia - The University of North Carolina at Chapel Hill
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial - The Lancet
Hemgenix shows efficacy among haemophilia B patients - PharmaTimes
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B - The New England Journal of Medicine
Pfizer Jettisons FDA-Approved Hemophilia B Gene Therapy Beqvez - CGTLive®
Hemophilia B Therapeutics Market Size in 7MM is expected to grow - openPR.com
(PDF) Treatment of hemophilia B: focus on recombinant factor IX - ResearchGate
Clinical trial: Hemophilia B, (NCT06379789) - CRISPR Medicine - CRISPR Medicine News
Anticipating Fitusiran’s Approval for Factor-Agnostic Hemophilia A, B, with Robert F. Sidonio Jr., MD, MSc - HCPLive
Pfizer stops commercialization of hemophilia gene therapy Beqvez - Reuters
FDA Approves Marstacimab, First Weekly Sub-Q Option for Hemophilia B - AJMC
First hemophilia B patients in Denmark treated with Hemgenix –... - Hemophilia News Today
News and Expert Insights in Hemophilia Gene Therapy for Bleeding Disorders Awareness Month 2025 - CGTLive®
Haemophilia B: My £2.6m blood has 'cured' my haemophilia - BBC
Be Bio raises $82m to advance haemophilia B gene therapy to Phase I/II trial - Pharmaceutical Technology
CSL Behring's Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia B - PR Newswire
Pfizer to Discontinue Its Hemophilia B Gene Therapy - MedPage Today
European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors - Business Wire
Pfizer stops selling hemophilia gene therapy, citing weak demand - BioPharma Dive
CSL Behring announces four-year results for haemophilia B gene therapy Hemgenix - PMLiVE
Sanofi, Alnylam Win First RNAi Approval for Hemophilia A and B - BioSpace
Haemophilia - The Lancet
World Haemophilia Day 2025 — Understanding The Rare Bleeding Disorder - ABP Live English
Pfizer pulls the plug on haemophilia gene therapy - FirstWord Pharma
Pfizer receives EU haemophilia B gene therapy approval - European Pharmaceutical Review
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Today
Be Bio secures $92m to advance BCM treatments - Pharmaceutical Technology
Centessa drops phase 2 hemophilia B drug in wake of Pfizer’s Hympavzi approval - Fierce Biotech
Pfizer shelves haemophilia gene therapy Beqvez amid low demand - Pharmaceutical Technology
CSL Behring treats two patients with gene therapy for haemophilia B - Clinical Trials Arena
Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio - Fierce Pharma
Germany will reimburse haemophilia gene therapy Hemgenix - Pharmaphorum
FDA Approves Pfizer's Hympavzi for Hemophilia A, B - Medscape
(PDF) Gene therapy for haemophilia: a very modern success story - ResearchGate
Pfizer’s bet on gene therapies in haemophilia has been a bust - Pharmaceutical Technology
Pfizer's haemophilia B gene therapy gets EU green light - Pharmaphorum
FDA approves Pfizer’s HYMPAVZI to treat haemophilia - Pharmaceutical Technology
Gene Therapy in Hemophilia: High Hopes and Costs, Low Uptake - Medscape
(PDF) Identification of Novel F9 Gene Variants in 143 Vietnamese Patients with Hemophilia B - ResearchGate
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors - Business Wire
An Observational Study of Glycopegylated Extended Half-Life Factor Prophylaxis in Hemophilia A and B in a Tertiary Care Center in India - Cureus
A phase 1/2 safety and efficacy study of TAK-754 gene therapy: The challenge of achieving durable factor VIII expression in haemophilia A clinical trials - Wiley Online Library
Pfizer quickly expands its hemophilia B gene therapy's reach with EU approval - Fierce Pharma
World Haemophilia Day: Women Can Have It Too, Here's the Truth - SheThePeople
Hympavzi Recommended for Approval in Europe for Severe Hemophilia A and B - Medscape
UKHCDO gene therapy taskforce: Guidance for implementation of haemophilia gene therapy into routine clinical practice for adults - Wiley Online Library
New Hemophilia Treatment Approved by FDA - Technology Networks
Development of SerpinPC as treatment for hemophilia halted by Centessa - Hemophilia News Today
Novo Nordisk A/S: Alhemo® recommended for European approval as first once-daily subcutaneous prophylactic treatment for people living with haemophilia A or B with inhibitors - Yahoo Finance
Value contribution of etranacogene dezaparvovec gene therapy in moderately severe and severe haemophilia B through multi-criteria decision analysis - Wiley Online Library
In about-face, hemophilia B therapy Hemgenix to be covered by NHS - Hemophilia News Today
Novo Nordisk’s Alhemo recommended by CHMP for haemophilia A and B - PMLiVE
Pfizer ducks out of Sangamo haemophilia A alliance - Pharmaphorum
Pfizer’s Hympavzi receives EC approval to treat haemophilia A and B patients - PMLiVE
Hemophilia B Market to Grow at a CAGR of 9% by 2029 | Industry - openPR.com
(fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B - Business Wire
(PDF) Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspective - ResearchGate
New gene therapy for hemophilia used for the first time in Austria - MedUni Wien
Haemophilia treatment with new delivery method approved - European Pharmaceutical Review
Personal Story: Ashley | Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
Alhemo Once-Daily Treatment for Hemophilia A, B with Inhibitors FDA Approved - Managed Healthcare Executive
CSL Behring’s Hemgenix administered to first haemophilia B patients in Europe - World Pharmaceutical Frontiers
EMA Authorizes Hemophilia B Gene Therapy - Medscape
Novo's once-daily haemophilia therapy scores FDA nod on second try - FirstWord Pharma
uniQure successfully defends haemophilia gene therapy patent against Pfizer - JUVE Patent
CSL Behring confirms long-term efficacy of HEMGENIX in hemophilia B treatment - Investing.com
Novo Nordisk wins hard-fought FDA approval for once-daily hemophilia med Alhemo - Fierce Pharma
Pfizer rounds out haemophilia portfolio with FDA approval - Pharmaphorum
What is the infected blood scandal and how much compensation will victims get? - BBC
Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virus - Frontiers
England, Denmark back CSL’s haemophilia B gene therapy - Pharmaphorum
Clinical analysis and quality of life survey of hemophilia B patients in the central and western regions of China - Frontiers
Personal Story: Carrie | Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
Pfizer infringed haemophilia therapy patent, says court - Life Sciences Intellectual Property Review
Pfizer infringed haemophilia B gene therapy patent - Progress Educational Trust
FDA approves Hympavzi for hemophilia - Medical Xpress
Pfizer bags EU okay for haemophilia drug Hympavzi - Pharmaphorum
Personal Story: Mikey | Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
NHS £2.6m blood infusion transforms life for haemophilia B patients - The Telegraph
Belief BioMed and Takeda China jointly announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved - The Manila Times
FDA Approves Second Gene Therapy for Hemophilia B - Medscape
Figure 1. (a) Profuse endotracheal bleeding at the time of admission... - ResearchGate
U.K. Patients To Get $3.3 Million Hemophilia Gene Therapy For Free - Forbes
Haemophilia: Causes and advancements in treatment that you should know - Hindustan Times
Figure 2. Identification of the breakpoints from two patients with... - ResearchGate
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
Patient perspective on living with mild hemophilia in Germany: results from a nationwide survey - Frontiers
ABPI cheers new gene therapy for IMF and innovative payment first - Association of the British Pharmaceutical Industry (ABPI)
First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark - Mynewsdesk
Study Examines Factors Linked With Bleeding Risk in Severe Hemophilia - Docwire News
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - The New England Journal of Medicine
CHESS II: Hemophilia Severity Correlates With Economic Burden, Patient QOL - AJMC
Explainer: Why Is Hemophilia B Called Christmas Disease? - Global Biotechnology Company
Novo Nordisk bleeding disorder injection gets USFDA nod - Medical Dialogues
Foreign Language Equivalents
Foreign Language Equivalents of 'haemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
haemophliia b,   haemophiliab ,   haemophiliaa b,   harmophilia b,   haemopholia b,   haemiphilia b,   haemophi;ia b,   hsemophilia b,   haemophhilia b,   haemopgilia b,   haemophulia b,   haemopilia b,   hhaemophilia b,   haenophilia b,   haemophiloa b,   hamophilia b,   haaemophilia b,   haemophikia b,   haemopjilia b,   haemophlia b,   haemophiliab,   haemoophilia b,   haemophiliia b,   haemophili ab,   haemophila b,   haeophilia b,   haemo[hilia b,   haemophilua b,   gaemophilia b,   haemophilia b,   haemohpilia b,   haemophili b,   heamophilia b,   haemohilia b,   haemphilia b,   haemophillia b,   haemophilia bb,   hemophilia b,   haemopphilia b,   hae,ophilia b,   hawmophilia b,   haemophiilia b,   haemophiila b,   haemophilia n,   haemophiia b,   haemophilia ,   haeomphilia b,   hameophilia b,   haemophilia v,   haempphilia b,   haemophilis b,   haemophilai b,   aemophilia b,   haemmophilia b,   jaemophilia b,   haemopihlia b,   haempohilia b,   ahemophilia b,   haeemophilia b,   haemoohilia b
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z